SAN DIEGO (AP) — SAN DIEGO (AP) — Organovo Holdings Inc. (ONVO) on Friday reported a loss of $2.5 million in its fiscal second quarter. The San Diego-based company said it had a loss of 14 cents per ...

ONVO READ THE FULL ONVO RESEARCH REPORT Organovo Holdings (NASDAQ:ONVO) is a biotechnology company that is both a developer of 3D tissue technology that has the potential to change the way treatments ...

The stock’s fifty day moving average price is $0.49 and its two-hundred day moving average price is $0.69. Organovo has a 52-week low of $0.40 and a 52-week high of $2.05. Get Organovo alerts: ...

at 08:10 Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases Organovo ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Investors in Organovo Holdings, Inc. (NASDAQ:ONVO) need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 16, 2019 $1.00... ARK Genomic ...

S&P 500 funds are inexpensive and share many similarities, but you'll find small differences in cost and how closely they track their benchmark.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bioprinting is an additive manufacturing process, wherein successive layers of cell-laden bioinks are used to form biological ...

Roth Capital Partners is managing the offering. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on ...